Christoph Brackmann - 01 Jan 2025 Form 3 Insider Report for NovoCure Ltd (NVCR)

Role: CFO
Signature: Steven Robbins, as attorney in fact for Brackmann, Christoph
Issuer symbol: NVCR
Transactions as of: 01 Jan 2025
Net transactions value: $0
Form type: 3
Filing time: 06 Jan 2025, 16:10:42 UTC
Next filing: 06 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NVCR	Ordinary Shares						11,200	01 Jan 2025	Direct
holding	NVCR	Restricted Share Units						60,277	01 Jan 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NVCR	Stock Options (Right to buy)							01 Jan 2025	Ordinary Shares	91,240	$16.59	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units that are scheduled to vest on November 4, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
F2	Options to buy 91,240 ordinary shares will vest in equal installments on each of November 4, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.